Testosterone Testing and Replacement Therapy in Suspected Hypogonadism
Diagnostic Testing Algorithm
- The American College of Gastroenterology recommends assessing for symptoms and signs of hypogonadism, including decreased energy, libido, muscle mass, body hair, as well as hot flashes, gynecomastia, and infertility in patients with suspected hypogonadism 2, 3
- Morning total testosterone concentration should be measured between 8 AM and 10 AM, and if total testosterone is low, the measurement should be repeated on a separate morning to confirm 1, 2
- In men with obesity or when total testosterone levels are near the lower limit of normal, free testosterone by equilibrium dialysis and sex hormone-binding globulin (SHBG) levels should be measured 2, 4, 5
Testosterone Replacement Therapy
- The American College of Gastroenterology recommends transdermal preparations, such as gel or patch, as first-line treatment for most patients due to convenience, providing stable day-to-day testosterone levels 2, 6
- Intramuscular injections may be considered, with dosage ranging from 50-400 mg every 2-4 weeks, but may result in fluctuating testosterone levels and injection discomfort 2, 6
- Implantable testosterone pellets may be considered as a long-term option, but require a procedure for implantation 2, 6
Monitoring
- Testosterone levels should be measured 2-3 months after starting treatment and after any dose change, with targets ranging from 500-600 ng/dL for injections and peak values 6-8 hours after patch application for transdermal preparations 2, 6
- Once stable, patients should be monitored every 6-12 months 2, 6
Benefits and Risks
- Testosterone replacement therapy may improve sexual function and libido, enhance sense of well-being, increase lean body mass and decrease body fat, and improve bone mineral density 2
- Potential risks include polycythemia, potential stimulation of prostate growth, and sleep apnea exacerbation, although recent evidence suggests no increased risk of MI or stroke even in high-risk patients 2
Common Pitfalls to Avoid
- Initiating therapy without confirming low testosterone with repeated morning measurements, failing to measure free testosterone in obese patients or those with borderline low total testosterone, and not completing appropriate diagnostic workup to determine the cause of hypogonadism should be avoided 2, 4